ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid

An, Meng-Fei; Shen, Chang; Zhang, Shao-Shi; Wang, Ming-Yue; Sun, Ze-Rui; Fan, Mao-Si; Zhang, Li-Juan; Zhao, Yun-Li*; Sheng, Jun*; Wang, Xuan-Jun*云南大学
Frontiers in Pharmacology2023-4-12DOI: 10.3389/fphar.2023.1128699
2被引25阅读
引用收藏
分享

摘要

Hesperetin is a natural flavonoid with many biological activities. In view of hyperuricemia treatment, the effects of hesperetin in vivo and in vitro, and the underlying mechanisms, were explored. Hyperuricemia models induced by yeast extract (YE) or potassium oxonate (PO) in mice were created, as were models based on hypoxanthine and xanthine oxidase (XOD) in L-O2 cells and sodium urate in HEK293T cells. Serum level of uric acid (UA), creatinine (CRE), and urea nitrogen (BUN) were reduced significantly after hesperetin treatment in vivo. Hesperetin provided hepatoprotective effects and inhibited xanthine oxidase activity markedly, altered the level of malondialdehyde (MDA), glutathione peroxidase (GSH-PX) and catalase (CAT), downregulated the XOD protein expression, toll-like receptor (TLR)4, nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, interleukin-18 (IL-18), upregulated forkhead box O3a (FOXO3a), manganese superoxide dismutase (MnSOD) in a uric acid-synthesis model in mice. Protein expression of organic anion transporter 1 (OAT1), OAT3, organic cationic transporter 1 (OCT1), and OCT2 was upregulated by hesperetin intervention in a uric acid excretion model in mice. Our results proposal that hesperetin exerts a uric acid-lowering effect through inhibiting xanthine oxidase activity and protein expression, intervening in the TLR4-NLRP3 inflammasome signaling pathway, and up-regulating expression of FOXO3a, MnSOD, OAT1, OAT3, OCT1, and OCT2 proteins. Thus, hesperetin could be a promising therapeutic agent against hyperuricemia.

学科与关键词

关键词
hesperetinhyperuricemiaxanthine oxidaseNLRP3excretion
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-04-12
卷期
第 14 卷
页码
1128699
DOI
10.3389/fphar.2023.1128699
语言
ENGLISH
成果收录
SCIE
资助标注
General Program of Applied Basic Research of Yunnan Province [202201AT070079]; Major Science and Technology Project of Yunnan Province [202202AA100004]; Yunnan Science and Technology Projects [202001AZ070001-062, 2018FG001-035]; Scientific Research Project of Yunnan Provincial Department of Education [2022Y265]; Reserve Talents of Young and Middle-aged Academic and Technical Leaders in Yunnan Province [202305AC160007]

作者

  • A

    An, Meng-Fei (第一作者)

    yunnan agr univ

  • S

    Shen, Chang

    yunnan agr univ

查看全部 10 位作者收起作者
  • Z

    Zhang, Shao-Shi

    yunnan agr univ

  • W

    Wang, Ming-Yue

    yunnan agr univ

  • S

    Sun, Ze-Rui

    yunnan agr univ

  • F

    Fan, Mao-Si

    yunnan agr univ

  • Z

    Zhang, Li-Juan

    yunnan univ

  • Z

    Zhao, Yun-Li (通讯)

    yunnan agr univ · yunnan univ

  • S

    Sheng, Jun (通讯)

    yunnan agr univ

  • W

    Wang, Xuan-Jun (通讯)

    yunnan agr univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417